These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5449789)

  • 1. [Congenital absence of the fibrin-stabilizing factor. (Factor 13)].
    Ciepielewska D; Lopaciuk S
    Pediatr Pol; 1970 Jul; 45(7):829-32. PubMed ID: 5449789
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children].
    Zuch A; Rudobielska M; Zwierzowa W; Jurgielewicz E; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1197-203. PubMed ID: 5085405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical laboratory characteristics of the severe form of hereditary fibrin-stabilizing factor (factor XIII) deficiency].
    Barkagan LZ; Arkhipov BF
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):54-8. PubMed ID: 7413627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of fibrin-stabilizing factor in the pathogenesis of hemorrhagic manifestations in viral hepatitis].
    Zhitar' VD
    Ter Arkh; 1973 Jul; 45(7):38-43. PubMed ID: 4755064
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma fibrin-stabilizing factor activity in acquired disease.
    Walls WD; Losowsky MS
    Br J Haematol; 1968 Sep; 15(3):327. PubMed ID: 5681498
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemorrhagic diathesis caused by a deficiency of the fibrin-stabilizing factor (factor 13)].
    Lechler E; Köhler J
    Verh Dtsch Ges Inn Med; 1968; 74():144-7. PubMed ID: 5714300
    [No Abstract]   [Full Text] [Related]  

  • 7. The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay.
    Sigg P
    Thromb Diath Haemorrh; 1966 Jan; 15(1):238-51. PubMed ID: 5919804
    [No Abstract]   [Full Text] [Related]  

  • 8. Deficiency of fibrin stabilizing factor (FSF) in kala-azar.
    Basu AK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1969 Apr; 17(2):35-6. PubMed ID: 5401878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reliability of simple examination methods for the measurement of fibrin stabilization and factor XIII activity].
    Popat D; Weber G; Wenzel E
    Med Welt; 1972 Sep; 23(40):1387-9. PubMed ID: 4655580
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic method for the quantitative determination of factor. XIII. Application to a familial deficiency.
    Janssen CL; Masure R
    Pathol Eur; 1970; 5(3):315-30. PubMed ID: 5477027
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factor 13 and protein 13].
    Duckert F
    Nouv Rev Fr Hematol; 1970; 10(5):685-90. PubMed ID: 4250291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor 13 (fibrin stabilizing factor) in the full-term newborn infant and in the suckling].
    Violante N; Paganetti G; Lattanzi E; Schettini F
    Boll Soc Ital Biol Sper; 1967 May; 43(10):535-7. PubMed ID: 6056665
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital factor XIII deficiency and increased fibrinolysis. A case report.
    Hathirat P; Jamieson BA; Beatty EC
    Rocky Mt Med J; 1970 Jun; 67(6):39-42. PubMed ID: 5431447
    [No Abstract]   [Full Text] [Related]  

  • 14. [Congenital deficiency of fibrin stabilizing activity. Presence of a protein immunologically analogous to factor XIII].
    Aguercif M; Nigg OM; Lopez JM; Bouvier CA
    Nouv Rev Fr Hematol; 1971; 11(6):841-8. PubMed ID: 4261156
    [No Abstract]   [Full Text] [Related]  

  • 15. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

  • 16. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Condition setting for the measurement of blood coagulation factor XIII activity using a fully automated blood coagulation analyzer, COAGTRON-350].
    Kanno N; Kaneko M; Tanabe K; Jyona M; Yokota H; Yatomi Y
    Rinsho Byori; 2012 Dec; 60(12):1131-8. PubMed ID: 23427694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII (fibrin-stabilizing factor) and platelets. I. Study of the association of factor XIII with blood platelets.
    Rolović Z
    Acta Med Iugosl; 1968; 22(1):113-23. PubMed ID: 5735663
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimation of plasma fibrin-stabilizing factor in families showing congenital deficiencies.
    Losowsky MS; Hall R
    Clin Sci; 1966 Feb; 30(1):171-8. PubMed ID: 5910931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of the fibrin stabilizing factor (FSF) in premature infants and in some childhood diseases].
    Lange MM; Lumare A; Varese L; De Sanctis C
    Minerva Pediatr; 1968 Jan; 20(1):13-8. PubMed ID: 5309586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.